Oral Valganciclovir Therapy in Infants Aged ≤2 Months with Congenital Cytomegalovirus Disease: A Multicenter, Single-Arm, Open-Label Clinical Trial in Japan

Our aims were to determine the clinical impact of oral valganciclovir (VGCV) in infants aged ≤2 months with congenital cytomegalovirus (CMV) disease and evaluate the efficacy of VGCV when initiated beyond the neonatal period. The multicenter, single-arm, open-label clinical trial was conducted in Ja...

Descripción completa

Detalles Bibliográficos
Autores principales: Morioka, Ichiro, Kakei, Yasumasa, Omori, Takashi, Nozu, Kandai, Fujioka, Kazumichi, Takahashi, Naoto, Yoshikawa, Tetsushi, Moriuchi, Hiroyuki, Ito, Yoshinori, Oka, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267258/
https://www.ncbi.nlm.nih.gov/pubmed/35806868
http://dx.doi.org/10.3390/jcm11133582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267258/
https://www.ncbi.nlm.nih.gov/pubmed/35806868
http://dx.doi.org/10.3390/jcm11133582

Ejemplares similares